New RP-HPLC method for the estimation of 6-mercaptopurine in rat plasma and various tissue homogenates

Journal of Liquid Chromatography and Related Technologies

Volumn 29, Issue 1, 2006, Pages 55-67

  Umrethia, M L ^a   Ghosh, P K ^a   Majithiya, R J ^a   Murthy, R S R ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

6 Mercaptopurine; HPLC method; Pharmacokinetic and biodistribution studies

Indexed keywords

ACETONITRILE; CENTRIFUGATION; CORRELATION METHODS; DRUG DOSAGE; PHARMACOKINETICS; PLASMAS; SAMPLING; TISSUE;

6-MERCAPTOPURINE; HPLC METHOD; PHARMACOKINETIC AND BIODISTRIBUTION STUDIES; RETENTION TIMES;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETONITRILE; MERCAPTOPURINE; METHANOL; METRONIDAZOLE; ORGANIC SOLVENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; FLOW RATE; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PLASMA; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPLEEN; STATISTICAL SIGNIFICANCE; TISSUE HOMOGENATE;

ANIMALIA;

EID: 29244432799     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070500362540     Document Type: Article

References (22)

1. Janine, E.; Friedman, J.M. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002, 65, 240-261.
2. Federico, I.; Antonello, D.P.; Barbara, L. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate. Cancer Chemother. Pharmacol. 1996, 37, 409-414.
3. Hayder, S.; Lafolie, P.; Bjork, O.; Peterson, C. 6-Mercaptopurine plasma levels in children with acute lymphoblastic leukemia: relation to relapse risk and myelotoxicity. Ther. Drug Monit. 1989, 11, 617.
4. Lafolie, P.; Hayder, S.; Bjork, O.; Ahstrom, L.; Liliemark, J.; Peterson, C. Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukemia and non-Hodgkin's lymphoma. Acta Paediatr. Scand. 1986, 75, 797.
5. Riccardi, R.; Balis, F.; Ferrara, P.; Lasorella, A.; Poplack, D.; Mastrangelo, R. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 1986, 3, 319.
6. Sulh, H.; Koren, G.; Whalen, C.; Soldin, S.; Zipursky, A.; Greenberg, M. Pharmacokinetic determinations of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia. Clin. Pharmacol. Ther. 1986, 40, 604.
7. Zimm, S.; Collins, J.M.; Riccardi, R.; O'Neill, D.; Narang, P.K.; Chabner, B.; Poplack, D.G. Variable bioavailability of oral mercaptopurine: is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?. N. Engl. J. Med. 1983, 308, 1005.
8. Lockhart, S.; Plunkett, W.; Jeha, S.; Ramirez, I.; Zipf, T.; Cork, A.; Pinkel, D. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia. J. Clin. Oncol. 1994, 12, 587.
9. Chalmers, A.H. A spectrophotometric method for the estimation of urinary azathioprine, 6-mercaptopurine, and 6-thiouric acid. Biochem. Med. 1975, 12 (3), 234-241.
10. Erb, N.; Haverland, U.; Harms, D.O.; Escherich, G.; Janka-Schaub, G. High performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 796 (1), 87-94.
11. Oliveira, B.M.; Romanha, A.J.; Alves, T.M.; Viana, M.B.; Zani, C.L. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells. Braz. J. Med. Biol. Res. 2004, 37 (5), 649-658.
12. Su, Y.; Hon, Y.Y.; Chu, Y.; Van de Poll, M.E.; Relling, M.V. Assay of 6-MP and its metabolites in patient plasma by high performance liquid chromatography with diode-array detection. Chromatogr B Biomed. Sci. Appl. 1999, 732 (2), 459-468.
13. Welch, J.; Lennard, L.; Morton, G.C.; Lilleyman, J.S. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose. Ther. Drug Monit. 1997, 19 (4), 382-385.
14. Tang, J.; Zhou, S.; Huang, L.; Huang, Y.; Zhang, H. Determination of azathiopurine and 6-mercaptopurine in serum by reversed-phase high performance liquid chromatography. Se Pu. 1998, 16 (6), 513-515.
15. Camparero, M.A.; Sacaba, B.; Garcia-Quelglas, E. J. Chromatogr. B 1998, 706, 311-317.
16. Innocenti, F.; Danesi, R.; Bocci, G.; Fogli, S.; Di Paolo, A.; Del-Tacca, M. Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens. Cancer Chemother. Pharmacol. 1999, 43 (2), 133-140.
17. Merodia, M.; Mirshahi, T.; Mirshahi, M. J. Chromatogr. 2000, 870, 159-167.
18. Gibaldi, M.; Perrier, D. Pharmacokinetics; Marcel Dekker, Inc: New York, 1982; 409-416.
19. Zimm, S.; Collins, J.M.; O'Neill, D.; Chabner, B.A.; Poplack, D.G. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin. Pharmacol. Ther. 1983, 34, 810.
20. Lennard, L.; Keen, D.; Lilleyman, J.S. Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations. Clin. Pharmacol. Ther. 1986, 40, 287.
21. Lennard, L.; Lilleyman, J.S.; Van Loon, J.; Weinshilboum, R.M. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet. 1990, 336, 225.
22. Lennard, L.; Lilleyman, J.S. Variable 6-mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J. Clin. Oncol. 1989, 7, 1816.